Amicus Therapeutics News and Activities

Presence

Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering novel high-quality therapies for people living with rare metabolic diseases. Its product offerings include enzyme replacement therapies and treatments for genetic disorders, serving a global patient pool.

The main services and products of Amicus Therapeutics:

  • Enzyme replacement therapies
  • Treatments for genetic disorders

2024 Revenue: Projected to be around $250 million

Employees: 500


Amicus Therapeutics is one of the...

Amicus Therapeutics is a company listed under the stock ticker FOLD (US).

Amicus Therapeutics has a direct presence in 5 countries.

Amicus Therapeutics has 4 subsidiaries including Amicus Therapeutics France, Amicus Therapeutics Germany and Amicus Therapeutics Spain.

Executives

View the org chart displaying its 36 main executives

Most searched biographies at Amicus Therapeutics

Create your alert
to follow the executive moves at Amicus Therapeutics.

Biotechnology

Amicus Therapeutics has 2,350 competitors including Astellas Gene Therapies (United States (USA)), Eurofins (Luxembourg) and Lonza (Switzerland).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Amicus Therapeutics
Social media about Amicus Therapeutics

Get in Touch

Call Amicus Therapeutics at +1 609...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Customized Data Solutions
Executives
Companies
The Official Board